1373503-48-0Relevant articles and documents
NOVEL COMPOUNDS
-
Page/Page column 46; 47, (2015/12/17)
Disclosed are novel retinoid-related orphan receptor gamma (RORγ) modulators and their use in the treatment of diseases mediated by RORγ.
COMBINATIONS OF HEPATITIS C VIRUS INHIBITORS
-
Page/Page column 540; 541, (2015/02/02)
The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.